Cue Biopharma Inc diskutieren
Cue Biopharma Inc
WKN: A2JAT5 / Symbol: CUE / Name: Cue Biopharma / Aktie / Small Cap /
0,67 €
7,14 %
Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target raised by analysts at Piper Sandler from $7.00 to $8.00. They now have an "overweight" rating on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Piper Sandler from $8.00 to $3.00. They now have an "overweight" rating on the stock.
Ratings data for CUE provided by MarketBeat
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
Neueste Beiträge
StockNews_com in Discuss Malibu Boats Inc. A